Cargando…
Histamine H(1) antagonist levocetirizine as a potential cause of lung injury
Histamine H(1) antagonists rarely cause drug-induced lung injury (DLI). A woman in her 60s, who had been taking antihistaminic levocetirizine for 2 months, presented with progressive cough and shortness of breath. A chest radiograph showed patchy infiltrations on both lower lung fields. Chest comput...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469143/ https://www.ncbi.nlm.nih.gov/pubmed/26090114 http://dx.doi.org/10.1002/rcr2.101 |
_version_ | 1782376596122894336 |
---|---|
author | Endo, Satoshi Yamamoto, Yasushi Minami, Yoshinori Okumura, Shunsuke Sasaki, Takaaki Ohsaki, Yoshinobu |
author_facet | Endo, Satoshi Yamamoto, Yasushi Minami, Yoshinori Okumura, Shunsuke Sasaki, Takaaki Ohsaki, Yoshinobu |
author_sort | Endo, Satoshi |
collection | PubMed |
description | Histamine H(1) antagonists rarely cause drug-induced lung injury (DLI). A woman in her 60s, who had been taking antihistaminic levocetirizine for 2 months, presented with progressive cough and shortness of breath. A chest radiograph showed patchy infiltrations on both lower lung fields. Chest computed tomography findings were consistent with non-specific interstitial pneumonia. Serum markers associated with interstitial pneumonias were elevated. Room air arterial blood gas analysis revealed hypoxemia. Restrictive ventilatory impairment was noted with reduced diffusing capacity. Transbronchial lung biopsy specimens demonstrated unclassifiable alveolitis. Steroid pulse therapy was introduced for respiratory distress, but the initial response to treatment was poor. A drug lymphocyte stimulation test was positive for levocetirizine. The interstitial pneumonia improved following withdrawal of levocetirizine. Her illness has not recurred under steroid therapy and the discontinuation of levocetirizine. Antihistaminics may have a potential risk of DLI. |
format | Online Article Text |
id | pubmed-4469143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BlackWell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-44691432015-06-18 Histamine H(1) antagonist levocetirizine as a potential cause of lung injury Endo, Satoshi Yamamoto, Yasushi Minami, Yoshinori Okumura, Shunsuke Sasaki, Takaaki Ohsaki, Yoshinobu Respirol Case Rep Case Reports Histamine H(1) antagonists rarely cause drug-induced lung injury (DLI). A woman in her 60s, who had been taking antihistaminic levocetirizine for 2 months, presented with progressive cough and shortness of breath. A chest radiograph showed patchy infiltrations on both lower lung fields. Chest computed tomography findings were consistent with non-specific interstitial pneumonia. Serum markers associated with interstitial pneumonias were elevated. Room air arterial blood gas analysis revealed hypoxemia. Restrictive ventilatory impairment was noted with reduced diffusing capacity. Transbronchial lung biopsy specimens demonstrated unclassifiable alveolitis. Steroid pulse therapy was introduced for respiratory distress, but the initial response to treatment was poor. A drug lymphocyte stimulation test was positive for levocetirizine. The interstitial pneumonia improved following withdrawal of levocetirizine. Her illness has not recurred under steroid therapy and the discontinuation of levocetirizine. Antihistaminics may have a potential risk of DLI. BlackWell Publishing Ltd 2015-06 2015-04-09 /pmc/articles/PMC4469143/ /pubmed/26090114 http://dx.doi.org/10.1002/rcr2.101 Text en © 2015 The Authors. Respirology Case Reports published by John Wiley & Sons Ltd on behalf of The Asian Pacific Society of Respirology. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Case Reports Endo, Satoshi Yamamoto, Yasushi Minami, Yoshinori Okumura, Shunsuke Sasaki, Takaaki Ohsaki, Yoshinobu Histamine H(1) antagonist levocetirizine as a potential cause of lung injury |
title | Histamine H(1) antagonist levocetirizine as a potential cause of lung injury |
title_full | Histamine H(1) antagonist levocetirizine as a potential cause of lung injury |
title_fullStr | Histamine H(1) antagonist levocetirizine as a potential cause of lung injury |
title_full_unstemmed | Histamine H(1) antagonist levocetirizine as a potential cause of lung injury |
title_short | Histamine H(1) antagonist levocetirizine as a potential cause of lung injury |
title_sort | histamine h(1) antagonist levocetirizine as a potential cause of lung injury |
topic | Case Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469143/ https://www.ncbi.nlm.nih.gov/pubmed/26090114 http://dx.doi.org/10.1002/rcr2.101 |
work_keys_str_mv | AT endosatoshi histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury AT yamamotoyasushi histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury AT minamiyoshinori histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury AT okumurashunsuke histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury AT sasakitakaaki histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury AT ohsakiyoshinobu histamineh1antagonistlevocetirizineasapotentialcauseoflunginjury |